Sandra M. Gurrola
VP of Finance, Ernexa Therapeutics Inc.
Companies
- Ernexa Therapeutics Inc.VP of Finance Sep 8, 2014 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Ernexa Therapeutics Inc. ERNA110 shares2$225 at $2.05Jun 21, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 21, 2025Exercised options 30 shares of Ernexa Therapeutics Inc.2
- Jun 21, 2024Shares withheld for tax 180 shares at $1.94 of Ernexa Therapeutics Inc.3
- Jun 21, 2024Exercised options 437 shares of Ernexa Therapeutics Inc.3
- Jun 21, 2023Shares withheld for tax 179 shares at $2.48 of Ernexa Therapeutics Inc.4
- Jun 21, 2023Exercised options 438 shares of Ernexa Therapeutics Inc.4
- Jun 21, 2022Shares withheld for tax 3,586 shares at $0.48 of Ernexa Therapeutics Inc.5
- Jun 21, 2022Exercised options 8,750 shares of Ernexa Therapeutics Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 25, 2024
- 4SEC EDGARForm 4 filed Jun 23, 2023
- 5SEC EDGARForm 4 filed Jun 23, 2022